|
|
Volumn 100, Issue 2, 2007, Pages 222-226
|
|
Effects of Valsartan Alone Versus Valsartan/Simvastatin Combination on Ambulatory Blood Pressure, C-Reactive Protein, Lipoproteins, and Monocyte Chemoattractant Protein-1 in Patients With Hyperlipidemia and Hypertension
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
C REACTIVE PROTEIN;
MONOCYTE CHEMOTACTIC PROTEIN 1;
SIMVASTATIN;
VALSARTAN;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BLOOD PRESSURE MONITORING;
BRAIN TUMOR;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATINE KINASE BLOOD LEVEL;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG WITHDRAWAL;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HEART PALPITATION;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
LIPOPROTEIN BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
MUSCLE CRAMP;
MYOPATHY;
OUTCOME ASSESSMENT;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RANDOMIZED CONTROLLED TRIAL;
REGRESSION ANALYSIS;
SIDE EFFECT;
SYSTOLIC BLOOD PRESSURE;
VERTIGO;
ANTIHYPERTENSIVE AGENTS;
ANTILIPEMIC AGENTS;
BIOLOGICAL MARKERS;
BLOOD PRESSURE MONITORING, AMBULATORY;
C-REACTIVE PROTEIN;
CHEMOKINE CCL2;
DOUBLE-BLIND METHOD;
DRUG COMBINATIONS;
DRUG SYNERGISM;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPIDEMIAS;
HYPERTENSION;
LIPOPROTEINS;
MALE;
MIDDLE AGED;
SIMVASTATIN;
TETRAZOLES;
VALINE;
|
|
EID: 34447253750
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjcard.2007.02.085 Document Type: Article |
|
Times cited : (29)
|
|
References (10)
|
